Phase 4 Psoriasis Trial, Recruiting NCT04347473 Sponsor: Psoriasis Treatment Center of Central New Jersey Condition: Psoriasis
Back to Psoriasis

Phase 4 Psoriasis Trial, Recruiting

NCT04347473
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, of any gender
  • People diagnosed with moderate-to-severe chronic plaque-type psoriasis, confirmed by specific clinical scores measuring how much of the body is affected and how severe the condition is (confirm with trial site for exact score thresholds)
  • People whose psoriasis has been assessed as a candidate for light therapy (phototherapy) and/or systemic (whole-body) medication
  • Women who could become pregnant must have a negative pregnancy test at the start of the trial, and must use an approved form of contraception throughout (options include hormonal contraception, an IUD, tubal ligation, a partner's vasectomy, or barrier methods such as a condom or diaphragm used with spermicide)

Who may not be able to join:

  • People who have a type of psoriasis other than the plaque form
  • Women who are pregnant, planning to become pregnant, or currently breastfeeding
  • People with a serious medical condition that is not well controlled and that, in the opinion of the trial doctor, could affect their safety during the study
  • People with active tuberculosis (TB) or an untreated latent (inactive but present) TB infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 6094434500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Psoriasis Treatment Center of Central New Jersey
Registry
ClinicalTrials.gov
Start date
6 April 2020
Est. completion
30 December 2020

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Body surface area

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov